Invention Grant
- Patent Title: E. coli-based production of beta-lactamase
-
Application No.: US17314583Application Date: 2021-05-07
-
Publication No.: US11542510B2Publication Date: 2023-01-03
- Inventor: Andrew Bristol , Michael Kaleko , Steven Hubert
- Applicant: Synthetic Biologics, Inc.
- Applicant Address: US MD Rockville
- Assignee: Synthetic Biologics, Inc.
- Current Assignee: Synthetic Biologics, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C12N15/70
- IPC: C12N15/70 ; C12P21/02 ; C12N9/86 ; C12N15/67 ; C12N15/09 ; C12N15/75
Abstract:
The invention relates to, in part, improved methods for the production of beta-lactamase using Escherichia coli (E. coli) cells. High yield production of beta-lactamase is achieved using methods of the invention.
Public/Granted literature
- US20210332373A1 E. COLI-BASED PRODUCTION OF BETA-LACTAMASE Public/Granted day:2021-10-28
Information query
IPC分类:
